Raimar Löbenberg
Raimar Löbenberg
Verified email at ualberta.ca - Homepage
TitleCited byYear
Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
E Galia, E Nicolaides, D Hörter, R Löbenberg, C Reppas, JB Dressman
Pharmaceutical research 15 (5), 698-705, 1998
8721998
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards
R Löbenberg, GL Amidon
European Journal of Pharmaceutics and Biopharmaceutics 50 (1), 3-12, 2000
8172000
Simulated biological fluids with possible application in dissolution testing
MRC Marques, R Loebenberg, M Almukainzi
Dissolution Technol 18 (3), 15-28, 2011
5142011
Targeted delivery of nanoparticles for the treatment of lung diseases
S Azarmi, WH Roa, R Löbenberg
Advanced drug delivery reviews 60 (8), 863-875, 2008
3742008
Current perspectives in dissolution testing of conventional and novel dosage forms
S Azarmi, W Roa, R Löbenberg
International Journal of pharmaceutics 328 (1), 12-21, 2007
2912007
Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung
JOH Sham, Y Zhang, WH Finlay, WH Roa, R Löbenberg
International Journal of Pharmaceutics 269 (2), 457-467, 2004
2892004
Interaction of poly (butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro
RN Alyaudtin, A Reichel, R Löbenberg, P Ramge, J Kreuter, DJ Begley
Journal of drug targeting 9 (3), 209-221, 2001
1992001
Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells
D Abrams, Y Huang, S McQuarrie, W Roa, H Chen, R Löbenberg, ...
1582006
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
S Azarmi, X Tao, H Chen, Z Wang, WH Finlay, R Löbenberg, WH Roa
International journal of pharmaceutics 319 (1-2), 155-161, 2006
1532006
Biorelevant dissolution media as a predictive tool for glyburide a class II drug
H Wei, R Löbenberg
european journal of pharmaceutical sciences 29 (1), 45-52, 2006
1452006
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit® E100
H Valizadeh, A Nokhodchi, N Qarakhani, P Zakeri‐Milani, S Azarmi, ...
Drug development and industrial pharmacy 30 (3), 303-317, 2004
1442004
Influence of the surfactant concentration on the body distribution of nanoparticles
L Araujo, R Löbenberg, J Kreuter
Journal of drug targeting 6 (5), 373-385, 1999
1431999
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
WH Roa, S Azarmi, MHDK Al-Hallak, WH Finlay, AM Magliocco, ...
Journal of controlled release 150 (1), 49-55, 2011
1342011
Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide
R Löbenberg, J Krämer, VP Shah, GL Amidon, JB Dressman
Pharmaceutical research 17 (4), 439-444, 2000
1292000
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after iv injection to rats
R Löbenberg, L Araujo, H von Briesen, E Rodgers, J Kreuter
Journal of controlled release 50 (1-3), 21-30, 1998
1271998
Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration
S Miyazaki, A Takahashi, W Kubo, J Bachynsky, R Löbenberg
J Pharm Pharm Sci 6 (2), 238-245, 2003
1092003
Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery
LG Sweeney, Z Wang, R Loebenberg, JP Wong, CF Lange, WH Finlay
International journal of pharmaceutics 305 (1-2), 180-185, 2005
1052005
Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly (d, l-lactide-co-glycolic acid) and polyalkylcyanoacrylate
P Lai, W Daear, R Löbenberg, EJ Prenner
Colloids and Surfaces B: Biointerfaces 118, 154-163, 2014
1002014
Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery—a review
S Gill, R Löbenberg, T Ku, S Azarmi, W Roa, EJ Prenner
Journal of Biomedical Nanotechnology 3 (2), 107-119, 2007
1002007
Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products
A Okumu, M DiMaso, R Löbenberg
European Journal of Pharmaceutics and Biopharmaceutics 72 (1), 91-98, 2009
972009
The system can't perform the operation now. Try again later.
Articles 1–20